EMA Authorised: Aripiprazole Zentiva (aripiprazole) — Zentiva, k.s.

View source ↗

Summary

The EMA has authorised Aripiprazole Zentiva (aripiprazole) for the treatment of schizophrenia and bipolar disorder. The marketing authorization holder is Zentiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Aripiprazole Zentiva (aripiprazole)

Snippet

Status: Authorised. Therapeutic area: Schizophrenia;Bipolar Disorder. MAH: Zentiva, k.s.. Decision date: 08/04/2026